- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Wells Fargo raises Nvidia stock price target to $265 on AI growth outlook | ||
| Fr | The Ensign Group stock price target raised to $206 from $177 at RBC Capital | ||
| Fr | Stryker stock rating reiterated at Outperform by RBC on strong growth outlook | ||
| Fr | MeiraGTx stock price target raised to $16 from $12 at RBC Capital | ||
| Fr | Paysafe stock price target lowered to $10 from $17 at RBC Capital | ||
| Fr | Ardent Health Partners stock price target lowered to $16 by RBC Capital | ||
| Fr | YDUQS Q3 2025 presentation: Premium segments and cash flow drive solid growth | ||
| Fr | Kuntarahoitus to redeem €100 million bond early | ||
| Fr | Silicon Motion unveils power-efficient PCIe Gen5 SSD controller | ||
| Fr | Angel acquires three top series to strengthen franchise ownership | ||
| Fr | Safe & Green Development reports record Q3 revenue growth | ||
| Fr | Mining royalty firm Vox appoints Joseph Gallucci to board of directors | ||
| Fr | Modular Medical submits FDA application for tubeless insulin patch pump | ||
| Fr | LM Funding Q3 2025 slides: Mining margin improves amid continued losses | ||
| Fr | Molina Healthcare wins $5 billion Florida Medicaid contract | ||
| Fr | Actelis Networks announces 1-for-10 reverse stock split | ||
| Fr | Piper Sandler lowers TELA Bio stock price target to $1.25 on soft Q3 results | ||
| Fr | Tres Tentos Q3 2025 slides: Record revenue surges 43% amid expansion strategy | ||
| Fr | SEALSQ to launch US-based post-quantum root of trust next week | ||
| Fr | Geode Capital Management discloses 2.24% stake in Avadel Pharmaceuticals | ||
| Fr | Inovio Pharmaceuticals stock price target raised to $6 by Piper Sandler | ||
| Fr | Piper Sandler lowers Nyxoah stock price target to $9 from $12 | ||
| Fr | Shore Bancshares stock price target raised to $18.50 by Piper Sandler | ||
| Fr | Stifel reiterates Buy rating on Columbia Sportswear stock amid leadership changes | ||
| Fr | Stifel reiterates Buy rating on Kymera Therapeutics stock ahead of December data |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .